Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curtis Cooper

Showing results (161-170 of 268) with videos related to

Pageof 27
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 21, 2017
Patient-Reported Outcomes Following Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Velpatasvir, With or Without VoxilaprevirZobair M Younossi, Maria Stepanova, Stuart Gordon, et al.
AIDS (London, England)|January 26, 2018
Hepatitis C virus cure does not impact kidney function decline in HIV co-infected patientsCarmine Rossi, Sahar Saeed, Joseph Cox, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 2022
Brief Report: Effect of Antiretroviral Switch From Tenofovir Disoproxil fumarate to Tenofovir Alafenamide on Alanine Aminotransferase, Lipid Profiles, and Renal Function in HIV/HBV-Coinfected Individuals in a Nationwide Canadian StudyArif Sarowar, Carla S Coffin, Scott Fung, et al.
The Journal of Infectious Diseases|March 23, 2012
Magnitude of virologic blips is associated with a higher risk for virologic rebound in HIV-infected individuals: a recurrent events analysisJ Troy Grennan, Mona R Loutfy, DeSheng Su, et al.
Journal of the International Association of Providers of AIDS Care|July 27, 2013
Impact of the Data Collection on Adverse Events of Anti-HIV Drugs cohort study on abacavir prescription among treatment-naive, HIV-infected patients in CanadaTony Antoniou, Jennifer Gillis, Mona R Loutfy, et al.
Medicine|June 1, 2018
Viral suppression and viral rebound among young adults living with HIV in CanadaAlexis Palmer, Karyn Gabler, Beth Rachlis, et al.
AIDS Care|July 21, 2016
An HIV-tailored quit-smoking counselling pilot intervention targeting depressive symptoms plus Nicotine Replacement TherapyLouise Balfour, Stephanie A Wiebe, William D Cameron, et al.
Ebiomedicine|March 11, 2026
Lack of harmonisation in immunological data: challenges in synthesising data during the COVID-19 pandemicNicole Shaver, Caroline Colijn, Jane Heffernan, et al.
Conflict and Health|October 2, 2008
Users' guides to the medical literature: how to use an article about mortality in a humanitarian emergencyEdward J Mills, Francesco Checchi, James J Orbinski, et al.
The Lancet. Infectious Diseases|June 18, 2013
Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trialMark Sulkowski, Stanislas Pol, Josep Mallolas, et al.
Pageof 27

Showing results (161-170 of 268) with videos related to

Sort By:
Pageof 27
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 21, 2017
Patient-Reported Outcomes Following Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Velpatasvir, With or Without VoxilaprevirZobair M Younossi, Maria Stepanova, Stuart Gordon, et al.
AIDS (London, England)|January 26, 2018
Hepatitis C virus cure does not impact kidney function decline in HIV co-infected patientsCarmine Rossi, Sahar Saeed, Joseph Cox, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 2022
Brief Report: Effect of Antiretroviral Switch From Tenofovir Disoproxil fumarate to Tenofovir Alafenamide on Alanine Aminotransferase, Lipid Profiles, and Renal Function in HIV/HBV-Coinfected Individuals in a Nationwide Canadian StudyArif Sarowar, Carla S Coffin, Scott Fung, et al.
The Journal of Infectious Diseases|March 23, 2012
Magnitude of virologic blips is associated with a higher risk for virologic rebound in HIV-infected individuals: a recurrent events analysisJ Troy Grennan, Mona R Loutfy, DeSheng Su, et al.
Journal of the International Association of Providers of AIDS Care|July 27, 2013
Impact of the Data Collection on Adverse Events of Anti-HIV Drugs cohort study on abacavir prescription among treatment-naive, HIV-infected patients in CanadaTony Antoniou, Jennifer Gillis, Mona R Loutfy, et al.
Medicine|June 1, 2018
Viral suppression and viral rebound among young adults living with HIV in CanadaAlexis Palmer, Karyn Gabler, Beth Rachlis, et al.
AIDS Care|July 21, 2016
An HIV-tailored quit-smoking counselling pilot intervention targeting depressive symptoms plus Nicotine Replacement TherapyLouise Balfour, Stephanie A Wiebe, William D Cameron, et al.
Ebiomedicine|March 11, 2026
Lack of harmonisation in immunological data: challenges in synthesising data during the COVID-19 pandemicNicole Shaver, Caroline Colijn, Jane Heffernan, et al.
Conflict and Health|October 2, 2008
Users' guides to the medical literature: how to use an article about mortality in a humanitarian emergencyEdward J Mills, Francesco Checchi, James J Orbinski, et al.
The Lancet. Infectious Diseases|June 18, 2013
Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trialMark Sulkowski, Stanislas Pol, Josep Mallolas, et al.
Pageof 27